Design Therapeutics, a biotech startup working on treatments for multiple nucleotide repeat disorders, emerged from stealth after raising $45 million in its Series A funding round. With the new capital it will press ahead with its research.
Sign up for Sigma Xi SmartBrief
News on scientific research and innovation
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.